16.11.2021 • News

Yiğitoğlu Appointed Exclusive Distributor of Cosmetic Ingredients Manufacturer Greaf

Greaf, a Shanghai-based cosmetic ingredients developer and manufacturer, has appointed Yiğitoğlu as the exclusive distributor partner for their whole product portfolio in Turkey.

Yiğitoğlu, the family-run Turkish chemical manufacturing, distribution and logistics services group that started commercial activities in 1956 and set out to expand its geographic footprint is making noticeable and quick progress when it comes to the company’s globalization efforts. The collaboration with Jaka Group company Greaf represents a major step forward in Yiğitoğlu’s strategy to enhance their business sector on specialty products.

Headquartered in Istanbul, the group’s service network spans across Turkey with regional directorates. Seven warehouses provide customers with smart storage technology and 85,000 sqm of storage capacity located in the most important industrial zones in Turkey. In addition, the network already includes an office in the Shanghai province in China.

Greaf, headquartered in Shanghai, is a Chinese manufacturer of a full range of high-quality active ingredients, from highly innovative and special patented technology to the more common type of products. The products are designed to beautify skin with advanced techniques, innovative active ingredients, and high-quality skincare solutions. Since 2010, Greaf expanded with branch offices in Beijing and Guangzhou, including the CMA-certified Jaka GMP plant and a 1.300 sqm R&I Center. With Yiğitoğlu Kimya as their exclusive partner, Greaf sets further steps in Europe.

Headquartered in Istanbul, Yiğitoğlu’s service network spans across Turkey...
Headquartered in Istanbul, Yiğitoğlu’s service network spans across Turkey with regional directorates.

Company

Logo:

Yiğitoğlu Kimya A.S.

Nispetiye Mah. Başlık Sok. MM Plaza No:3 Kat:5 A-B Blok
Etiler-Beşiktaş/İstanbul
Turkey

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.